Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

338 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effects of Somatic Methylation in Colonic Polyps on Risk of Developing Metachronous Advanced Colorectal Lesions.
Murcia O, Martínez-Roca A, Juárez M, Giner-Calabuig M, Alustiza M, Mira C, Mangas-Sanjuan C, Serrano E, Ruiz-Gómez FA, Baile-Maxia S, Medina L, Alenda C, Payá A, Rodriguez-Soler M, Zapater P, Jover R. Murcia O, et al. Among authors: jover r. Cancers (Basel). 2021 Jan 11;13(2):246. doi: 10.3390/cancers13020246. Cancers (Basel). 2021. PMID: 33440809 Free PMC article.
Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer.
Piñol V, Castells A, Andreu M, Castellví-Bel S, Alenda C, Llor X, Xicola RM, Rodríguez-Moranta F, Payá A, Jover R, Bessa X; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Piñol V, et al. Among authors: jover r. JAMA. 2005 Apr 27;293(16):1986-94. doi: 10.1001/jama.293.16.1986. JAMA. 2005. PMID: 15855432
Clinical performance of original and revised Bethesda guidelines for the identification of MSH2/MLH1 gene carriers in patients with newly diagnosed colorectal cancer: proposal of a new and simpler set of recommendations.
Rodríguez-Moranta F, Castells A, Andreu M, Piñol V, Castellví-Bel S, Alenda C, Llor X, Xicola RM, Jover R, Payá A, Bessa X, Balaguer F, Cubiella J, Argüello L, Morillas JD, Bujanda L; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Rodríguez-Moranta F, et al. Among authors: jover r. Am J Gastroenterol. 2006 May;101(5):1104-11. doi: 10.1111/j.1572-0241.2006.00522.x. Am J Gastroenterol. 2006. PMID: 16696788
Detection of metachronous neoplasms in colorectal cancer patients: identification of risk factors.
Ballesté B, Bessa X, Piñol V, Castellví-Bel S, Castells A, Alenda C, Paya A, Jover R, Xicola RM, Pons E, Llor X, Cordero C, Fernandez-Bañares F, de Castro L, Reñé JM, Andreu M; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Ballesté B, et al. Among authors: jover r. Dis Colon Rectum. 2007 Jul;50(7):971-80. doi: 10.1007/s10350-007-0237-2. Dis Colon Rectum. 2007. PMID: 17468913
The efficacy of adjuvant chemotherapy with 5-fluorouracil in colorectal cancer depends on the mismatch repair status.
Jover R, Zapater P, Castells A, Llor X, Andreu M, Cubiella J, Balaguer F, Sempere L, Xicola RM, Bujanda L, Reñé JM, Clofent J, Bessa X, Morillas JD, Nicolás-Pérez D, Pons E, Payá A, Alenda C; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Jover R, et al. Eur J Cancer. 2009 Feb;45(3):365-73. doi: 10.1016/j.ejca.2008.07.016. Epub 2008 Aug 21. Eur J Cancer. 2009. PMID: 18722765
Utility of p16 immunohistochemistry for the identification of Lynch syndrome.
Payá A, Alenda C, Pérez-Carbonell L, Rojas E, Soto JL, Guillén C, Castillejo A, Barberá VM, Carrato A, Castells A, Llor X, Andreu M, Koh J, Enders GH, Benlloch S, Jover R. Payá A, et al. Among authors: jover r. Clin Cancer Res. 2009 May 1;15(9):3156-62. doi: 10.1158/1078-0432.CCR-08-3116. Epub 2009 Apr 21. Clin Cancer Res. 2009. PMID: 19383812 Free PMC article.
338 results